Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B S Roden

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Virology|October 9, 2018
Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccinationJin Qiu, Shiwen Peng, Ying Ma, et al.
Cell & Bioscience|December 25, 2024
Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methodsShiwen Peng, Darrell Fan, Hsin-Fang Tu, et al.
Journal of Virology|June 15, 2022
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human CancerPola Olczak, Ken Matsui, Margaret Wong, et al.
Mbio|January 20, 2021
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 AntibodyShiwen Peng, Louise Ferrall, Stephanie Gaillard, et al.
Vaccine|September 19, 2015
Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopesSubhashini Jagu, Balusubramanyam Karanam, Joshua W Wang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 21, 2021
Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccineAlexander Marin, Ananda Chowdhury, Sarah M Valencia, et al.
Journal of Biomedical Science|April 30, 2021
A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventionsSsu-Hsueh Tseng, Brandon Lam, Yu Jui Kung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88Rongcun Yang, Francisco Martinez Murillo, Michael J Delannoy, et al.
Plos One|July 8, 2014
Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV PseudovirionsJoshua W Wang, Subhashini Jagu, Chenguang Wang, et al.
Plos One|September 13, 2011
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cellsRavi K Anchoori, Saeed R Khan, Thanasak Sueblinvong, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Virology|October 9, 2018
Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccinationJin Qiu, Shiwen Peng, Ying Ma, et al.
Cell & Bioscience|December 25, 2024
Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methodsShiwen Peng, Darrell Fan, Hsin-Fang Tu, et al.
Journal of Virology|June 15, 2022
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human CancerPola Olczak, Ken Matsui, Margaret Wong, et al.
Mbio|January 20, 2021
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 AntibodyShiwen Peng, Louise Ferrall, Stephanie Gaillard, et al.
Vaccine|September 19, 2015
Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopesSubhashini Jagu, Balusubramanyam Karanam, Joshua W Wang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 21, 2021
Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccineAlexander Marin, Ananda Chowdhury, Sarah M Valencia, et al.
Journal of Biomedical Science|April 30, 2021
A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventionsSsu-Hsueh Tseng, Brandon Lam, Yu Jui Kung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88Rongcun Yang, Francisco Martinez Murillo, Michael J Delannoy, et al.
Plos One|July 8, 2014
Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV PseudovirionsJoshua W Wang, Subhashini Jagu, Chenguang Wang, et al.
Plos One|September 13, 2011
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cellsRavi K Anchoori, Saeed R Khan, Thanasak Sueblinvong, et al.
Pageof 14